• "Minimal" holoprosencephaly in a 14q deletion syndrome patient
• 14q12q13.2 microdeletion syndrome: Clinical characterization of a new patient, review of the literature, and further evidence of a candidate region for CNS anomalies
• 14q32.11 microdeletion including CALM1, TTC7B, PSMC1, and RPS6KA5: A new potential cause of developmental and language delay in three unrelated patients
• A 14q distal chromoanagenesis elucidated by whole genome sequencing
• A 50-kb deletion disrupting the RSPO2 gene is associated with tetradysmelia in Holstein Friesian cattle
• A child with multiple congenital anomalies due to partial trisomy 7q22.1 → qter resulting from a maternally inherited balanced translocation: a case report and review of literature
• A complex eIF4E locus impacts the durability of va resistance to Potato virus Y in tobacco
• A Complex Karyotype in a 68-Year-Old Patient With T-PLL
• A distinct neurodevelopmental syndrome with intellectual disability, autism spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8
• An early onset benign myopathy with glycogen storage caused by a de novo 1.4 Mb-deletion of chromosome 14
• An unusual case of nephrotic syndrome in a microcephalic infant: Questions
• Analysis of copy number variation in dogs implicates genomic structural variation in the development of anterior cruciate ligament rupture
• Anesthetic Management of an Infant with a Chromosome 14q Terminal Deletion Syndrome
• Anophthalmia, Global Developmental Delay, and Severe Dysphagia in a Young Girl With 14q22q23 Microdeletion Syndrome
• BCL2 and miR-15/16: from gene discovery to treatment
• Beta-Spectrin Deletion Responsible for Hereditary Spherocytosis: When New Technologies Are Not the Key to Success
• Candidate sex-associated gene identification in Trachinotus ovatus (Carangidae) using an integrated SLAF-seq and bulked segregant analysis approach
• Child Neurology: Siblings with infantile epilepsy and developmental delay: A circuitous path to genomic diagnosis
• Chromosomal instability in a patient with ring chromosome 14 syndrome: a case report
• Chromosomal translocation t(11;14) and p53 deletion induced by the CRISPR/Cas9 system in normal B cell-derived iPS cells
• Chromosome 14 deletions, rings, and epilepsy genes: A riddle wrapped in a mystery inside an enigma
• Chromosome 14q32.2 Imprinted Region Disruption as an Alternative Molecular Diagnosis of Silver-Russell Syndrome
• Chronic lymphocytic leukemia with t(14 ;18) and trisomy 12: a case report
• Clinical and genetic features of 45,X maleness: A case report and review of the literature
• Comparison of IGH Profile Signals Using t(4;14) and IGH Break-Apart Probes by FISH in Multiple Myeloma
• Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India
• Deficiency and overexpression of <em>Rtl1</em> in the mouse cause distinct muscle abnormalities related to Temple and Kagami-Ogata syndromes
• Deletion of conserved non-coding sequences downstream from NKX2-1: A novel disease-causing mechanism for benign hereditary chorea
• Delineation of the frequency and boundary of chromosomal copy number variations in paediatric neuroblastoma
• Diagnosis of FOXG1 syndrome caused by recurrent balanced chromosomal rearrangements: case study and literature review
• Disseminated Intravascular Coagulation Associated with Large Deletion of Immunoglobulin Heavy Chain
• Downregulation of ZC3H14 driven by chromosome 14q31 deletion promotes hepatocellular carcinoma progression by activating integrin signaling
• Early-onset movement disorder as diagnostic marker in genetic syndromes: Three cases of FOXG1-related syndrome
• Endocrinological features of a patient with 14q microdeletion and Dubowitz phenotype
• Enforced expression of MIR142, a target of chromosome translocation in human B-cell tumors, results in B-cell depletion
• Enhancer adoption caused by genomic insertion elicits interdigital <em>Shh</em> expression and syndactyly in mouse
• Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes
• Expanded Prader-Willi Syndrome due to an Unbalanced de novo Translocation t(14;15): Report and Review of the Literature
• First Case Report of Prader-Willi-Like Syndrome in Colombia
• Frequency, variations, and prognostic implications of chromosome 14q32 deletions in chronic lymphocytic leukemia
• From DNA human sequence to the chromatin higher order organisation and its biological meaning: Using biomolecular interaction networks to understand the influence of structural variation on spatial genome organisation and its functional effect
• Further evidence that full gene deletions of DICER1 predispose to DICER1 syndrome
• Generation of induced pluripotent stem cell line GZHMCi006-A from amniotic fluid-derived cells with deletion 14q syndrome
• Genetic analysis of a case of chromosome 14q microdeletion
• Genomic analysis of arginine vasopressin gene in riverine buffalo reveals its potential association with silent estrus behavior
• Genomic analysis of multiple myeloma using targeted capture sequencing in the Japanese cohort
• Growth Hormone Improves Short-Term Growth in Patients with Temple Syndrome
• Guideline recommendations for diagnosis and clinical management of Ring14 syndrome-first report of an ad hoc task force
• Hereditary spherocytosis caused by copy number variation in SPTB gene identified through targeted next-generation sequencing
• HIF1alpha is not a target of 14q deletion in clear cell renal cancer
• HIF1α is not a target of 14q deletion in clear cell renal cancer
• Hypoxaemia and interstitial lung disease in an infant with hypothyroidism and hypotonia
• Identification and Candidate Gene Evaluation of a Large Fast Neutron-Induced Deletion Associated with a High-Oil Phenotype in Soybean Seeds
• Identification of two 14q32 deletions involving DICER1 associated with the development of DICER1-related tumors
• Imprinting disorders in humans: a review
• Insights from the genetic characterization of central precocious puberty associated with multiple anomalies
• Intellectual disability in two Chinese sisters caused by a 3p26.3p25.3 microdeletion and a 14q32.13q32.33 microduplication inherited from the mother with 46, XX, t (3, 14) (p25; q32)
• Kagami-Ogata syndrome in a patient with 46,XX,t(2;14)(q11.2;q32.2)mat disrupting MEG3
• Kagami-Ogata syndrome: an important differential diagnosis to Beckwith-Wiedemann syndrome
• Maternal interchromosomal insertional translocation leading to 1q43-q44 deletion and duplication in two siblings
• Maternally inherited 133kb deletion of 14q32 causing Kagami-Ogata syndrome
• Maternally inherited deletion encompassing the RTL1as and MEG8 genes of the human 14q32 imprinted region in a patient with a mild Kagami-Ogata syndrome phenotype
• MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation
• Microdeletion of pseudogene chr14.232.a affects LRFN5 expression in cells of a patient with autism spectrum disorder
• MicroRNA 200a as a histologically independent marker for meningioma recurrence: Results of a four microRNA panel analysis in meningiomas
• Molecular and clinical studies in 8 patients with Temple syndrome
• Molecular characterization of small supernumerary marker chromosomes derived from chromosome 14/22 detected in adult women with fertility problems: Three case reports and literature review
• Molecular characterization of temple syndrome families with 14q32 epimutations
• Multiple DICER1-related tumors in a child with a large interstitial 14q32 deletion
• Narrowing down the Common Cytogenetic Deletion 14q to a 5.6-Mb Critical Region in 1p/19q Codeletion Oligodendroglioma-Relapsed Patients Points to Two Potential Relapse-Related Genes: SEL1L and STON2
• New insights into the imprinted MEG8-DMR in 14q32 and clinical and molecular description of novel patients with Temple syndrome
• New insights into the phenotypic spectrum of 14q22q23 deletions: a case report and literature review
• Newly diagnosed multiple myeloma patients carrying monoallelic deletion of the whole locus of immunoglobulin heavy chain gene have a better prognosis compared to those with t(4;14) and t(14;16)
• Novel 14q32.2 paternal deletion encompassing the whole DLK1 gene associated with Temple syndrome
• Overexpression of lncRNA DLEU1 in Gastric Cancer Tissues Compared to Adjacent Non-Tumor Tissues
• Preimplantation genetic testing for a chr14q32 microdeletion in a family with Kagami-Ogata syndrome and Temple syndrome
• Prenatal diagnosis and molecular cytogenetic characterization of a de novo 3.19-Mb chromosome 14q32.13-q32.2 deletion of paternal origin
• Pulmonary Infantile Hemangioma Mimicking a Congenital Cystic Adenomatoid Malformation
• Ring Chromosome 14 with a Terminal 14q32.33 Deletion
• Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation-dependent probe amplification
• Seeing the diagnosis on karyotype-SOX2 and eye development
• Simultaneous Quantification of t(14;18) and HPRT Exon 2/3 Deletions in Human Lymphocytes
• Temple syndrome and Kagami-Ogata syndrome: clinical presentations, genotypes, models and mechanisms
• Temple syndrome as a differential diagnosis to Prader-Willi syndrome: Identifying three new patients
• Temple Syndrome: Clinical Findings, Body Composition and Cognition in 15 Patients
• Terminal 14q32.33 deletion as a novel cause of agammaglobulinemia
• The Brain-Lung-Thyroid syndrome (BLTS): A novel deletion in chromosome 14q13.2-q21.1 expands the phenotype to humoral immunodeficiency
• The Effects of 5 Years of Growth Hormone Treatment on Growth and Body Composition in Patients with Temple Syndrome
• The effects of five years of growth hormone treatment on growth and body composition in patients with Temple syndrome
• The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion
• The FRA14B common fragile site maps to a region prone to somatic and germline rearrangements within the large GPHN gene
• The impact of cytogenetics on duration of response and overall survival in patients with relapsed multiple myeloma (long-term follow-up results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial
• The marker effects of a single-step random regression model for 4 test-day traits in German Holsteins
• The marker effects of a single-step random regression model for four test-day traits in German Holstein
• The multiple myelomas - current concepts in cytogenetic classification and therapy
• The renal cancer risk allele at 14q24.2 activates a novel hypoxia-inducible transcription factor-binding enhancer of DPF3 expression
• Two Abnormal Cell Lines of Trisomy 14 and t(X;14) with Skewed X-Inactivation
• Unbalanced 14;X Translocation and Pattern of X Inactivation in a Female Patient with Multiple Congenital Anomalies
• UPD(14)mat and UPD(14)mat in concomitance with mosaic small supernumerary marker chromosome 14 in two new patients with Temple syndrome
• Whole exome sequencing identifies a novel 5 Mb deletion at 14q12 region in a patient with global developmental delay, microcephaly and seizures